To the Editor: We described a successful treatment of a case diagnosed with arrhythmogenic right ventricular cardiomyopathy (ARVC) with absent pulmonary valve (APV).

A 10-year-old male child was referred to our emergency room for acute right heart failure who had two times of syncope before. On admission, the electrocardiogram showed that T-wave inversions were visible in most leads, QRS duration was prolonged with 120 ms, and the terminal depolarizations might be interpreted as epsilon waves in leads V1--V5 \[[Figure 1a](#F1){ref-type="fig"} arrows\]. Transthoracic echocardiography and computed tomography scan were performed; the right ventricle chamber seemed larger than the left ventricle chamber \[[Figure 1b](#F1){ref-type="fig"}\], with APV, atrial septal defect, and moderate tricuspid regurgitation.

![(a) Electrocardiogram showing that terminal depolarizations might be interpreted as epsilon waves in leads V1--V5 (arrows). (b) Computed tomography scan indicating the right ventricle chamber significantly enlarged. (c--e) The pathologic pictures showing fatty infiltration of right ventricle free wall and absent of pulmonary valve. (f) The leaflets were reconstructed independently using autologous pericardium in the situation with intact pulmonary annulus.](CMJ-130-1383-g001){#F1}

On the basis of the diagnosis of ARVC combined with APV and for the frequent episodes of symptomatic dyspnea, the patient underwent pulmonary valve reconstruction and atrial defect closure. Fatty infiltration of right ventricle free wall and absent of pulmonary valve were detected during the operation and only inferior-posterior wall contained a little myocardial fiber \[Figure [1c](#F1){ref-type="fig"}--[1e](#F1){ref-type="fig"}\]. In the situation with intact pulmonary annulus, three leaflets were reconstructed independently using autologous pericardium treated with 0.6% glutaraldehyde solution for 10 min \[[Figure 1f](#F1){ref-type="fig"}\]. For the frequent episodes of syncope, the patient underwent implantation of a biventricular defibrillator.

The patient had been followed for 12 months and had experienced symptomatic improvement with return to the New York Heart Association Class I/II symptoms without any sustained ventricular arrhythmias or ICD discharges since surgery.

ARVC is a genetic form of cardiomyopathy characterized by fibrofatty replacement of predominantly right ventricular (RV) myocardium and is one of the leading causes of sudden unexpected cardiac death in young, apparently healthy individuals.\[[@ref1]\] As disease progresses, RV dilation and RV dysfunction may occur. The patients with unexplained syncope, non-sustained ventricular tachycardia, familial history of sudden death are potential candidates for Implantable Cardioverter Defibrillator (ICD) implantation even in the absence of ventricular arrhythmias.\[[@ref2]\] APV is a rare congenital heart disease with severe pulmonary insufficiency, characterized with aneurysmal dilation in the pulmonary artery. Because RV volume overload from significant pulmonary insufficiency may in turn worsen RV function, surgical correction of pulmonary insufficiency could have therapeutic benefit. Symptoms usually appear between the ages of 30--50 years in ARVC patients and sudden death may be the first manifestation of the disease, mostly in previously asymptomatic young people and athletes.\[[@ref3]\] In case of older patients, the clinical presentation is mainly represented by signs and symptoms of right heart failure.\[[@ref4]\] Our case report showed in young patients, how this disease may present at the beginning with acute right heart failure, without ventricular arrhythmias but with episodes of symptomatic bradycardia that require the reconstruction of pulmonary valve and use of cardiac resynchronization therapy to avoid the well-known, long-term adverse effects of the right ventricular pacing.
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